本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

52.18
-1.2100-2.27%
成交量:6.72万
成交额:353.48万
市值:50.45亿
市盈率:-10.96
高:52.91
开:52.91
低:52.03
收:53.39
52周最高:78.00
52周最低:44.12
股本:9,669.26万
流通股本:9,316.62万
量比:2.53
换手率:0.07%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
净资产收益率:-26.09%
总资产收益率:-14.20%
市净率:2.89
市盈率(LYR):-8.06

数据加载中...

2026/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/11

重要事件披露

Form 8-K - Current report
2026/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities